Skip to main content

Artemis II Moon Mission

Berlin, April 2, 2026 – In a  2023 interview with Berlin Partner, Irene Selvanathan, founder and CEO of NEUROSPACE, set an ambitious course: “Our ultimate goal is to send the first German rover to the moon within the next two to three years – designed and built in Berlin.” Today, that ambition is becoming reality. Her company is part of the first crewed lunar mission since Apollo 17. When NASA’sArtemis II mission lifted off on April 2 at 0:35 a.m. CET, the NEUROSPACE-developed satellite TACHELES began its journey into space as well.

NEUROSPACE’s participation was made possible through a German-American space agreement between the German Aerospace Center (DLR) and NASA.  The collaboration underscores the strength of German satellite technology on the global stage. For NEUROSPACE, it marks the most significant milestone in the company’s history to date – supported throughout by Berlin Partner for Business and Technology.

TACHELES was officially handed over to NASA on Sept. 16, 2025, at the Kennedy Space Center in Florida. The 12U CubeSat is equipped with NEUROSPACE’s proprietary HiveR rover technology During the mission, it will enter a highly elliptical orbit with an apogee of approximately 77,000 kilometers, passing through the heart of the Van Allen radiation belts. There, if all proceeds as planned, the satellite will examine the effects of extreme radiation and temperature fluctuations on electronic components. The objective: to validate the durability and reliability of rover technology under real space conditions. How resilient is TACHELES? To extend the satellite’s originally planned 28-hour lifespan to several days –  and potentially up to 2.5 years – NEUROSPACE will execute a dedicated propulsion maneuver during the mission. This maneuver, however, is subject to one clear condition: the safety of the four astronauts aboard Artemis II must not be compromised.

Selvanathan also emphasized in her 2023 interview: “We’re Berliners, and we feel very much at home here –  it was important for us to establish Berlin as our headquarters.” That decision has proven its value. Berlin’s space industry is innovative, diverse and exceptionally well connected. Satellite technology, in particular, is a focal point of the region’s research and development landscape. Should NEUROSPACE succeed in extending TACHELES’ operational life, the data and insights generated could help drive further breakthroughs in space research.

For everyone else, NEUROSPACE’s website –  and ongoing media coverage – offer a front-row seat to Berlin’s latest chapter in space exploration.

TeilenShare

TOMORROW'S HEALTH. THINKING IN BERLIN TODAY.

27.01.2022
Ada Health is an AI-powered app that helps people to better understand and manage their health and find the next steps for the right treatment.

Read more

SUCCESS STORY: BERLIN SETS ITS SIGHTS HIGH

27.01.2022
LifeEO, based in Kreuzberg, Germany, has developed an artificial intelligence that uses satellite data to monitor the safety of rail lines, power lines and infrastructure worldwide.

Read more

WHO Pandemic Early Warning Centre:

27.01.2022
The World Health Organization (WHO) will open a Global Hub for Pandemic and Epidemic Intelligence in Berlin this year, creating shared access to critical multisectoral data to better identify future health threats.

Read more

Venture Leap

27.01.2022
During the Corona crisis, this young company from the Charlottenburg Innovation Center (CHIC) developed its Probatix software - now a successful SaaS product that is in use throughout Germany.

Read more

BERLIN SIMPLIFIES PROCESSES.

27.01.2022
5Micron is developing a contactless sensor system that anonymously records encounters, but also movement patterns, for example in entrance zones. This function is intended to contribute to relieving the burden of everyday processes.

Read more

BERLIN IS ONE OF THE WORLD'S TOP LOCATIONS

27.01.2022
In recent years, the capital region has established itself as the leading German location for the healthcare industry, especially in the field of life sciences.

Read more